Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?
Arcutis Biotherapeutics Ownership Summary
Arcutis Biotherapeutics is owned by 114.26% institutional investors, 1.80% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.69% of ARQT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.44% of its assets in Arcutis Biotherapeutics shares.
ARQT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcutis Biotherapeutics | 114.26% | 1.80% | -16.06% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 19.17M | 14.69% | $506.69M |
| Suvretta capital management | 12.44M | 9.61% | $326.10M |
| Blackrock | 8.62M | 7.76% | $80.19M |
| Frazier life sciences management | 9.87M | 7.63% | $258.91M |
| Rubric capital management lp | 8.27M | 6.39% | $216.88M |
| State street | 7.72M | 5.91% | $204.00M |
| Vanguard group | 7.25M | 5.68% | $210.65M |
| Polar capital | 6.61M | 5.11% | $173.23M |
| Ubs group | 5.53M | 4.24% | $146.24M |
| Morgan stanley | 5.30M | 4.06% | $139.99M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 1.01M | 10.58% | $26.65M |
| Suvretta capital management | 12.44M | 5.96% | $326.10M |
| Frazier life sciences management | 9.87M | 5.64% | $258.91M |
| Ally bridge group (ny) | 233.22K | 2.68% | $4.40M |
| Rubric capital management lp | 8.27M | 1.99% | $216.88M |
| Privium fund management b.v. | 333.19K | 1.71% | $8.81M |
| Pavaki capital management | 187.00K | 1.68% | $4.94M |
| Fishman jay a ltd/mi | 597.12K | 1.27% | $15.78M |
| 1492 capital management | 113.46K | 1.01% | $3.00M |
| Orbimed advisors | 2.04M | 1.00% | $53.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 19.17M | 0.01% | 8.63M |
| Ubs group | 5.53M | 0.02% | 2.20M |
| Orbimed advisors | 2.04M | 1.00% | 2.04M |
| Blackrock | 8.62M | 0.00% | 1.96M |
| State street | 7.72M | 0.01% | 1.90M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilder gagnon howe | 1.31M | 0.36% | -2.99M |
| Paradigm biocapital advisors lp | - | - | -1.47M |
| Perceptive advisors | - | - | -1.36M |
| Driehaus capital management | 878.43K | 0.13% | -1.35M |
| Braidwell lp | - | - | -1.30M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Orbimed advisors | 2.04M | 1.00% | 2.04M | $53.54M |
| Simplify asset management | 865.86K | 0.37% | 865.86K | $22.88M |
| Public sector pension investment board | 774.31K | 0.04% | 774.31K | $20.33M |
| Norges bank | 392.30K | 0.00% | 392.30K | $10.29M |
| Longaeva partners | 344.80K | 0.20% | 344.80K | $9.04M |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -7.00 |
| Massmutual trust co fsb/adv | -7.00 |
| National bank of canada /fi/ | -12.00 |
| Advisory services network | -19.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 303 | 7.07% | 149,136,761 | 12.56% | 114 | 1.11% | 192 | 41.18% | 69 | -33.65% |
| Jun 30, 2026 | 280 | 0.72% | 132,367,241 | -0.02% | 102 | 0.98% | 137 | -5.52% | 101 | 14.77% |
| Mar 31, 2026 | 270 | -6.90% | 129,847,548 | 0.58% | 102 | 1.00% | 141 | -19.43% | 86 | 11.69% |
| Dec 31, 2025 | 127 | -48.79% | 34,362,908 | -72.69% | 26 | 0.27% | 72 | -40.98% | 38 | -54.22% |
| Sep 30, 2025 | 87 | -63.14% | 29,200,444 | -76.92% | 22 | 0.23% | 44 | -63.64% | 25 | -62.69% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.88M | 5.44% | -5.71K |
| Polar Capital Biotech S Inc | 6.26M | 4.98% | - |
| Vanguard US Total Market Shares ETF | 3.59M | 3.03% | 492.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.59M | 2.85% | 13.03K |
| Vanguard Total Stock Mkt Idx Inv | 3.57M | 2.85% | 33.08K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.57M | 2.85% | 33.08K |
| State Street® SPDR® S&P® Biotech ETF | 3.24M | 2.56% | 84.83K |
| iShares Russell 2000 ETF | 2.90M | 2.29% | - |
| Jennison Health Sciences Equity | 2.27M | 1.90% | - |
| PGIM Jennison Health Sciences Z | 2.27M | 1.89% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 04, 2026 | Matsuda Masaru | EVP, Chief Legal Officer | Sell | $1.37M |
| Nov 02, 2026 | Matsuda Masaru | EVP, Chief Legal Officer | Sell | $38.84K |
| Nov 02, 2026 | Burnett Patrick | EVP, Chief Medical Officer | Sell | $30.05K |
| Nov 02, 2026 | Watanabe Todd | See Remarks | Sell | $139.47K |
| Oct 15, 2026 | Welgus Howard G. | - | Sell | $127.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 5 |
| 2026 Q3 | - | 13 |
| 2026 Q2 | - | 12 |
| 2026 Q1 | - | 26 |
| 2025 Q4 | - | 32 |
ARQT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools